- Politics & Government
Japan OKs Insurance Coverage for Novel Alzheimer’s Drug
12:45 JST, December 13, 2023
Tokyo (Jiji Press)—A Japanese health ministry advisory panel Wednesday approved public medical insurance coverage for a novel Alzheimer’s drug developed by Japanese drugmaker Eisai Co. and its U.S. partner Biogen Inc.
The decision was made by the Central Social Insurance Medical Council, which advises the health minister.
The state-set official price of the drug is expected to be ¥2.98 million per year for a patient weighing 50 kilograms.
The drug, lecanemab, will be covered with public medical insurance from Dec. 20 and be put into clinical use by the end of the year at the earliest.
The ministry approved the production and sale of the drug in Japan in late September.
In the United States, the drug was formally approved in July, with its wholesale price standing at $26,500 per year.
In Japan, expensive drugs are covered by the so-called high-cost medical expense benefit system, which caps patients’ out-of-pocket costs, so most of the expenses for lecanemab will be shouldered by public medical insurance.
The drug is expected to slow the progression of symptoms in patients in the early stages of the disease.
In a clinical trial, 18-month administration of the drug to such patients reduced the decline in cognitive function by 27 pct compared with patients who were not administered the drug, according to Eisai.
"Politics" POPULAR ARTICLE
Japan, U.S., South Korea Swiftly Share Radar Info for First Time, Letting Japan Track North Korean Missile More Quickly
China Deploys Multiple Warships Around Self-Claimed ADIZ
U.S. Warned Japan of China’s Hacking of Official Diplomatic Telegram System; Reinforcing Cybersecurity Key Concern
4 Chinese Warships Deployed Around Taiwan, Sources Say; Believed Ships Will Collaborate with Other Warships in East China Sea
Prime Minister Kishida to Meet Kenyan President William Ruto in Tokyo; Plans to Expand Bilateral Cooperation in Defense
JN ACCESS RANKING
- Japan Business Delegation, Chinese Premier Li Meet; Both Sides Tout Importance of Bilateral Economic Ties
- Japan Eyes 45 B. Yen in Aid for Optical Semiconductors
- Japan’s Job Availability Ratio Rises for 2nd Straight Year
- North Korean Workers in China Riot over Unpaid Wages; 2,000 Occupy Factory, Kill Plant Manager
- Business, Labor Leaders Reaffirm Vow to Raise Wages in Shunto Talks